China's Pharmaceutical Industry - Porter’s Five Forces Strategy Analysis:

China's Pharmaceutical Industry - Porter’s Five Forces Strategy Analysis

Published Date: October 2008

Published By: Aruvian Research

Page Count: 22

Order Code: R3456-253

Questions About This Report

E-mail a Colleague

Printable Page

Fax Your Order

Description

Table of Contents

Search Inside
this Report

Similar
Products

Pharmaceutical is one of the most intense “Knowledge Driven” industries, which is continually in a state of dynamic transition.Diversities in life forms and diseases pose stiff challenge to the design of specific and targeted solutions. The process of “drug discovery/invention” is elaborate requiring on an average 8-10 years at a cost of US$ 300 million to reach a new drug to the market.

Aruvian Research analyzes China's Pharmaceutical Industry in the Michael Porter’s Five Forces Analysis. It uses concepts developed in Industrial Organization (IO) economics to derive five forces that determine the competitive intensity and therefore attractiveness of a market. Porter referred to these forces as the microenvironment, to contrast it with the more general term macroenvironment. They consist of those forces close to a company that affect its ability to serve its customers and make a profit. A change in any of the forces normally requires a company to re-assess the marketplace.

Similar Products

• Pharmaceutical Alliance Management

Published Jan 2009 by Cutting Edge Information

• New Drug Development from Existing Drugs

Published Dec 2008 by Trimark Publications

• What Is the Future Role of Predictive Safety Biomarkers in Drug Development?

Published Dec 2008 by Decision Resources

• ENDOMETRIOSIS Therpay Pipeline Report

Published Dec 2008 by Life Science Analytics (LSA)

• DYSMENORRHEA Therpay Pipeline Report

Published Dec 2008 by Life Science Analytics (LSA)

• CONTRACEPTION Therpay Pipeline Report